Transforming somatic mutations of mammalian target of rapamycin kinase in human cancer

E-ISSN： 1349-7006|106|12|1687-1692

ISSN： 1347-9032

Source： Cancer Science, Vol.106, Iss.12, 2015-12, pp. : 1687-1692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

EVI1, a target gene for amplification at 3q26, antagonizes transforming growth factor‐β‐mediated growth inhibition in hepatocellular carcinoma

Cancer Science, Vol. 106, Iss. 7, 2015-07 ,pp. : 929-937

John Wiley & Sons Inc

Access to resources Recommend Favorite

Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma

Cancer Science, Vol. 1347-9032, Iss. 9, 2015-09 ,pp. : 1118-1129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma

Cancer Science, Vol. 106, Iss. 9, 2015-09 ,pp. : 1118-1129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Catechol‐O‐methyltransferase, a new target for pancreatic cancer therapy

Cancer Science, Vol. 106, Iss. 5, 2015-05 ,pp. : 576-583

John Wiley & Sons Inc

Access to resources Recommend Favorite

Comprehensive transcriptomic analysis of molecularly targeted drugs in cancer for target pathway evaluation

Cancer Science, Vol. 106, Iss. 7, 2015-07 ,pp. : 909-920

John Wiley & Sons Inc

Access to resources Recommend Favorite